Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
NCT ID: NCT06360458
Last Updated: 2025-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE3
928 participants
INTERVENTIONAL
2024-08-01
2030-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Methylprednisolone Sodium Succinate With Endovascular ThRombectomy for Large Ischemic STroke
NCT07175649
Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia
NCT07202143
Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke
NCT06870448
Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion
NCT07141303
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Methylprednisolone sodium succinate group
No interventions assigned to this group
Placebo group
Methylprednisolone sodium succinate simulant
Placebo
Intravenous injection of placebo (Chongqing Lummy Pharmaceutical Co., Ltd., 40mg/bottle) with a dose of 2mg/kg (maximum dose of 160mg), once daily, for three consecutive days. The initial study drug will be administered as soon as possible after randomization. It is recommended that the initial study drug administrated before arterial access closure, but it should not be delayed more than 2 hours after arterial access closure.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Methylprednisolone sodium succinate
Intravenous injection of methylprednisolone sodium succinate (Chongqing Lummy Pharmaceutical Co., Ltd., 40mg/bottle) with a dose of 2mg/kg (maximum dose of 160mg), once daily, for three consecutive days. The initial study drug will be administered as soon as possible after randomization. It is recommended that the initial study drug administrated before arterial access closure, but it should not be delayed more than 2 hours after arterial access closure.
Placebo
Intravenous injection of placebo (Chongqing Lummy Pharmaceutical Co., Ltd., 40mg/bottle) with a dose of 2mg/kg (maximum dose of 160mg), once daily, for three consecutive days. The initial study drug will be administered as soon as possible after randomization. It is recommended that the initial study drug administrated before arterial access closure, but it should not be delayed more than 2 hours after arterial access closure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The time from onset to randomization was within 12 hours.
* Anterior circulation ischemic stroke was preliminarily determined according to clinical symptoms or imaging examination.
* Occlusion of the intracranial internal carotid artery, the M1- or M2-segment of the middle cerebral artery by confirmed by CT angiography (CTA), MR angiography (MRA), or digital subtraction angiography (DSA).
* Baseline National Institutes of Health Stroke Scale (NIHSS) ≥ 6.
* Baseline Alberta Stroke Program Early CT Score (ASPECTS) \< 6 (based on non-contrast CT or MRI) and/or core infarct volume ≥ 50 ml (based on CTP with rCBF \< 30%).
* Planned treatment with endovascular thrombectomy (EVT).
* Informed consent obtained from patients or their legal representatives.
Exclusion Criteria
* mRS score \> 2 before onset.
* Pregnant or lactating women.
* Allergic to contrast agents or glucocorticoids.
* Participating in other clinical trials.
* The artery is tortuous so that the thrombectomy device cannot reach the target vessel.
* Bleeding history (gastrointestinal and urinary tract bleeding) in recent 1 month.
* Chronic hemodialysis and severe renal insufficiency (glomerular filtration rate \< 30 ml/min or serum creatinine \> 220 umol/L \[2.5 mg/ dL\]).
* Life expectancy due to any advanced disease \< 6 months.
* Follow-up is not expected to be completed.
* Intracranial aneurysm and arteriovenous malformation.
* Brain tumors with imaging mass effect.
* Systemic infectious disease.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wan-Jin Chen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wan-Jin Chen
Vice President of Fujian Medical University and Vice President of The First Affiliated Hospital of Fujian Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of USTC
Hefei, Anhui, China
Hefei First People's Hospital
Hefei, Anhui, China
Taihe County People's Hospital
Taihe Chengguanzhen, Anhui, China
Yijishan Hospital of Wannan Medical College
Wuhu, Anhui, China
Anxi County Hospital
Anxi, Fujian, China
Anxi Hospital of Traditional Chinese Medicine
Anxi, Fujian, China
Fuqing City Hospital of Fujian
Fuqing, Fujian, China
Fuzhou University Affiliated Provincial Hospital
Fuzhou, Fujian, China
Union Hospital Affiliated to Fujian Medical University
Fuzhou, Fujian, China
The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine
Fuzhou, Fujian, China
Department of Neurology, First Affiliated Hospital Fujian Medical University
Fuzhou, Fujian, China
900th Hospital of PLA Joint Logistic Support Force
Fuzhou, Fujian, China
Longyan First Affiliated Hospital of Fujian Medical University
Longyan, Fujian, China
Nanping First Hospital
Nanping, Fujian, China
Mindong Hospital
Ningde, Fujian, China
Ningde Municipal Hospital, Ningde Normal University
Ningde, Fujian, China
Putian University Affiliated Hospital
Putian, Fujian, China
The First Hospital of Putian City
Putian, Fujian, China
Quanzhou First Hospital Affiliated to Fujian Medical University
Quanzhou, Fujian, China
The 910th Hospital of the Joint Logistics Support Force of the Chinese PLA
Quanzhou, Fujian, China
The Second Affiliated Hospital of Fujian Medical University
Quanzhou, Fujian, China
Sanming First Hospital
Sanming, Fujian, China
Shaowu Municiple Hospital
Shaowu, Fujian, China
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China
Zhongshan Hosipital Xiamen University
Xiamen, Fujian, China
909th Hospital of PLA Joint Logistic Support Force
Zhangzhou, Fujian, China
Zhangzhou Municipal Hospital of Fujian Province
Zhangzhou, Fujian, China
Gansu Province Central Hospital
Lanzhou, Gansu, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Maoming Hospital of Traditional Chinese Medicine
Maoming, Guangdong, China
Maoming people's hospital
Maoming, Guangdong, China
Shantou Central Hospital
Shantou, Guangdong, China
Affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangdong, China
Central people' s hospital of zhanjiang
Zhanjiang, Guangdong, China
Red Cross Hospital of Yulin City
Yulin, Guangxi, China
Guangzhou First People's Hospital
Guangzhou, Guangzhou, China
The First People's Hospital of Qingzhen
Qingzhen, Guizhou, China
The First Affiliated Hospital of Hainan Medical University
Haikou, Hainan, China
The Second Affiliated Hospital of Hainan Medical University
Haikou, Hainan, China
Biyan People's Hospital
Bishui, Henan, China
Xihua People's Hospital
Wacheng Neighborhood, Henan, China
Zhoukou Centeral Hospital
Zhoukou, Henan, China
ZhuMaDian Centeral Hospital
Zhumadian, Henan, China
Zhumadian First People's Hospital
Zhumadian, Henan, China
The Central Hospital of Enshi Tujia And Miao Automomous Prefecture
Enshi, Hubei, China
Ezhou Central Hospital
Ezhou, Hubei, China
Qichun People's Hospital
Huanggang, Hubei, China
Huanggang Central Hospital
Huanggang, Hubei, China
Huangshi Central Hospital
Huangshi, Hubei, China
Yangtze University Affiliated Hospital
Jingzhou, Hubei, China
Jingzhou Hospital Affiliated to Yangtze University
Jingzhou, Hubei, China
Lichuan City Ethnic Traditional Chinese Medical Hospital
Lichuan, Hubei, China
Shiyan Hospital of Integrated Traditional and Western Medicine
Shiyan, Hubei, China
Shiyan Renmin Hospital
Shiyan, Hubei, China
Taihe Hospital Affiliated to Hubei University of Medicine
Shiyan, Hubei, China
The First People's Hospital of Tianmen in Hubei Province
Tianmen, Hubei, China
Wuhan Hankou Hospital
Wuhan, Hubei, China
The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Wuhan NO.1 Hospital
Wuhan, Hubei, China
Tongji hospital, Tongji medical college, Huazhong university of science and technology
Wuhan, Hubei, China
The Third People's Hospital of Hubei Province
Wuhan, Hubei, China
Wuhan University Renmin Hospital
Wuhan, Hubei, China
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
The First people's Hospital of Jiangxia District
Wuhan, Hubei, China
Xiangyang Hospital of Traditional Chinese Medicine
Xiangyang, Hubei, China
Xiangyang No.1 People's Hospital, Hubei University of Medicine.
Xiangyang, Hubei, China
Xianning Central Hospital
Xianning, Hubei, China
The Second People's Hospital of Yichang
Yichang, Hubei, China
Baotou Central Hospital
Baotou, Inner Mongolia, China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
First Affiliated Hospital of Gannan Medical University
Ganzhou, Jiangxi, China
Ganzhou People's Hospital, Ganzhou (G.Z.)
Ganzhou, Jiangxi, China
Jingdezhen First People's Hospital
Jingdezhen, Jiangxi, China
Jiujiang University Affiliated Hospital
Jiujiang, Jiangxi, China
The First People's Hospital of Jiujiang
Jiujiang, Jiangxi, China
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China
The First Affiliated Hospital, Jiangxi Medical College, Nanchang University
Nanchang, Jiangxi, China
Yingtan people's hospital
Yingtan, Jiangxi, China
The First People's Hospital of Xianyang
Xianyang, Shaanxi, China
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Jinan, Shandong, China
Jinan Central Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China
Liaocheng People's Hospital
Liaocheng, Shandong, China
Liaocheng third people's hospital
Liaocheng, Shandong, China
The Affiliated Hospital of Qingdao Univercity
Qingdao, Shandong, China
The Second Affiliated Hospital of Shandong First Medical University
Tai’an, Shandong, China
Zoucheng People's Hospital, Shandong Province
Zoucheng, Shandong, China
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
Cardiovascular Hospital Affiliated to Shanxi Medical University
Taiyuan, Shanxi, China
Shanxi Provincial People's Hospital
Taiyuan, Shanxi, China
Chongzhou People's Hospital
Chengdu, Sichuan, China
Gulin County People's Hospital
Gulin, Sichuan, China
Mianyang 404 Hospital
Mianyang, Sichuan, China
Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Mianyang, Sichuan, China
Affiliated Hospital of North Sichuan Medical College
Nanchong, Sichuan, China
Suining Central Hospital
Suining, Sichuan, China
Zigong Third People's Hospital
Zigong, Sichuan, China
Tianjin Huanhu Hospital
Tianjin, Tian, China
Bozhou People's Hospital
Bole, Xinjiang, China
Qujing NO.1 Hospital
Qujing, Yunnan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MRCTA,ECFAH of FMU[2024]368-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.